Patricia Kelly Yeo
Business Insider
Los Angeles, CA, United States
Contact Patricia
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Patricia:
How DNA-testing startup Helix became one of the nation's leading coronavirus tracking labs
Inside Helix, the genomics company that helped the CDC track the Alpha variant's spread within the US, and where it plans to go from here. → Read More
From guaranteeing full-time work to giving out gas cards, the shorthanded home-care industry is pulling out all the stops to hire more caregivers
Employers in the fragmented home-care industry are trying almost anything to hire and retain workers in a tight labor market. → Read More
Home-care agencies say they're desperate to hire caregivers amid a labor 'shortage' in near-minimum-wage jobs
Home-care employers are struggling to find new staff as prospective applicants look elsewhere for income. Some point to bigger unemployment checks. → Read More
A Morgan Stanley analyst note lays out how Amazon could reshape the way companies provide healthcare
A new Morgan Stanley analyst note predicts that the tech giant's employee clinics and generic drug platform could make it a formidable competitor. → Read More
The doctor behind 'The Vagina Bible' wrote a new book on menopause, and she says she's skeptical of the startups targeting middle-aged women
In advance of her new book "The Menopause Manifesto," Dr. Jen Gunter spoke to Insider on the most overlooked aspect of women's health. → Read More
A Cityblock alum raised $10 million for her app taking a preventive, group therapy approach to mental health
After dropping out of a clinical psychology master's, Ariela Safira founded Real, a consumer mental health app with a preventive approach to illness. → Read More
Moderna's mRNA technology could help in the decades-long search for an HIV vaccine
"We had such a spectacular outcome with coronavirus that we absolutely need to embark on this platform and test it," a veteran HIV researcher said. → Read More
Biden's infrastructure plan earmarks $400 billion in home-based care for aging Americans — and it could shake up the lucrative home care industry
Biden's jobs plan takes a pro-union stance on the lucrative home healthcare industry and spotlights the US's elderly population and its caregivers. → Read More
Despite 23andMe's declining revenue, CEO Anne Wojcicki said she's committed to consumer-first healthcare 'entirely outside the system'
23andMe CEO Anne Wojcicki said its consumer-focused philosophy hasn't wavered since day one. 23andMe is set to go public via SPAC later this year. → Read More
Investors have poured $169 million into digital weight loss apps like Noom. Some experts think it's nothing new.
Apps like Noom want to get users to lose weight through their digital health platforms, but experts say they're taking the same diet culture approach. → Read More
We just got the best look yet at the consumer genetics market ahead of 23andMe's public debut. Here are the 5 biggest obstacles the $3.6 billion company will have to overcome.
Insider analyzed the 323-page regulatory filing made public Friday that outlined its plans to go public via SPAC. → Read More
A new kind of healthcare startup wants health insurers to pay for meal kits and groceries for food insecure seniors
Project Well wants to curb both food insecurity and chronic disease costs by working with insurers to care for seniors. → Read More
This summer is going to be fun, finally — but far from normal
18 doctors and scientists share their predictions and plans for this summer, from sleep-away camp to national-park trips. → Read More
Why the pandemic's focus on infectious diseases won't reshape the drug industry, according to 3 top life science VCs
The pandemic may have made infectious disease a public health priority, but these top biotech VC's don't think it's going to change the drug industry. → Read More
We're only 'just scratching the surface' on companies like 23andMe that map out our DNA. One analyst lays out what could take the industry to the next level.
The future of consumer genomics lies in healthcare partnerships and drug development, according to a new CB Insights report released last week. → Read More
Pfizer CEO vows to speed up new vaccine development to under 100 days to combat the 'high likelihood' that current COVID-19 shots become ineffective
Speaking at Davos, Pfizer CEO Albert Bourlas said there's a "high possibility" coronavirus vaccines will become ineffective in the future. → Read More
Billionaire investor Vinod Khosla says healthcare's biggest problems can be solved with AI. Here's his vision for 2030's healthcare system.
Vinod Khosla thinks AI will aid in 80% of healthcare decisions. Predictive data will help doctors treat patients before they develop symptoms. → Read More
A top VC shares why biotechs that harness the microbiome to battle diseases could soar in 2021
Microbiome companies could see a resurgence in 2021. BI identified four to watch that are turning the microbiome into targeted drug therapies. → Read More
Silicon Valley billionaire investor Vinod Khosla said involving industry insiders in Pfizer and BioNTech's vaccine early in development 'would have slowed down' progress
Silicon Valley billionaire investor Vinod Khosla said that "experts" would have "slowed down" Pfizer and Moderna vaccine progress. → Read More
Big Pharma is set to sell $40 billion worth of COVID-19 vaccines in 2021
Drug industry analysts predict how 2021 will play out for Pfizer, Moderna, and the global market for COVID-19 mRNA coronavirus vaccines. → Read More